Microalbuminuria is a strong predictor of cardiovascular disease. Previous studies are inconsistent regarding the relationship between microalbuminuria and insulin resistance syndrome. Therefore, we examined this relationship in 1031 young adults (61% Caucasian, 39% AfricanAmerican) aged 19 to 32 years. Individuals with either urinary albumin to creatinine ratio at or above the 90th percentile (age, race, and gender specific) or urinary albumin level at or above 30 mg/L were considered as having slightly elevated albumin excretion (microalbuminuria). The multiple risk variables of insulin resistant syndrome measured include body mass index, waist circumference, blood pressure (BP), triglycerides, high-density lipoprotein (HDL) cholesterol, glucose, insulin, insulin resistance index (calculated from a homeostasis model assessment equation), and uric acid. After controlling for age and gender, African-Americans with microalbuminuria by either measure had higher mean systolic (P < < .001) and diastolic (P < < .05) BP, prevalence of hypertension (P < < .05), and, contrary to expectations, HDL cholesterol (P < < .05) than those without this condition. On the other hand, Caucasians showed no such associations. In African-Americans, the above differences in BP levels persisted when hypertensive subjects were excluded. None of the other risk variables displayed any relation to microalbuminuria in both races. These results suggest that microalbuminuria is not necessarily an intrinsic component of the insulin resistance syndrome, at least in the young adult age. Furthermore, the observed association between hypertension and microalbuminuria among young African-Americans may reflect early evidence of renal dysfunction due to the burden of elevated BP in this group. Am
T hat microalbuminuria is a strong predictor of diabetic nephropathy and cardiovascular risk is now well recognized.
1,2 Several studies have reported increased prevalence of hypertension, dyslipidemia, obesity, and insulin resistance/hyperinsulinemia among nondiabetic subjects with microalbuminuria. [3] [4] [5] [6] It has been suggested that microalbuminuria could be linked to multiple cardiovascular risk factors through insulin resistance, 3, 6 ,7 a condition known as insulin resistance syndrome. 8, 9 Most of the studies linking microalbuminuria to insulin resistance syndrome were performed either in relatively older diabetic and hypertensive subjects 10, 11 or population groups with a high prevalence of obesity and type 2 diabetes. 3 Observations in presumably healthy subjects in this regard gave conflicting results. 4, 6, 7, [12] [13] [14] Moreover, it is not clear whether microalbuminuria is part of insulin resistance syndrome in youth.
As part of the Bogalusa Heart Study, a biracial (African-American-Caucasian) community-based investigation of early natural history of cardiovascular disease, 15 we previously examined the association between microalbuminuria and BP levels in youth, and found a positive relationship only among AfricanAmericans. 5 This study examines the relationship between microalbuminuria and cardiovascular risk variables of insulin resistance syndrome in these subjects.
METHODS

Study Population
In 1988 -1991, a cohort of young adults aged 19 -32 years was examined as part of the Bogalusa Heart Study in the biracial (65% Caucasian, 35% African-American) community of Bogalusa, Louisiana. For the present study, 1031 individuals (66% Caucasian, 53% women) were chosen after the following exclusions because of 1) protein or blood (1ϩ or greater) in the urine as determined by Ames Multistix (Miles, Inc., Elkast, IN), 2) albumin to creatinine ratio greater than 30 mg/mmol (the upper limit for microalbuminuria), 3) pregnancy, 4) taking either antidiabetic drugs or insulin, and 5) missing data on study variables.
General Examination Subjects were instructed to fast for 12-14 hours before examination; the compliance was ascertained by interview on the morning of the examination. Urine sample (not necessarily the first one) and antecubital venous blood were collected before other screening procedures.
Height, weight, and waist circumference were measured in replicates. Body mass index (BMI ϭ weight in kilograms divided by the square of the height in meters) and waist circumference were used as measures of general adiposity and visceral fat deposition, respectively. Replicate (six times) BP measurements were performed by two randomly assigned nurses on the right arm of subjects in a relaxed, sitting position. Systolic blood pressure (SBP) was recorded at the first Korotkoff phase, diastolic blood pressure (DBP) was measured at both the fourth and fifth phases. The fifth phase was used to determine diastolic hypertension and the fourth phase was used in the rest of the analysis because of its reliability in young age group. Mean of replicates were used in all analyses. Subjects were classified as hypertensive if they had SBP higher than 140 mm Hg, had fifth-phase DBP higher than 90 mm Hg, or had been treated for hypertension.
Microalbuminuria was determined on the morning spot urine sample by an enzyme linked immunosorbent assay (ELISA) procedure using Albuwell kit (Exocell, Philadelphia, PA). It has been shown that an early morning spot urine gives a reasonable estimate of the 24-h excretion of urinary albumin. 16 Urinary creatinine was determined by the Jaffe reaction using a commercial kit (Sigma Chemica, St. Louis, MO). Urinary albumin (milligrams per liter) to creatinine (millimoles per liter) ratio (ACR) was used as a measure of albumin excretion. Expressing albumin excretion as ACR would attenuate any short-term variability in urinary albumin excretion. 13, 17 Clinical microalbuminuria is usually defined as a urinary ACR of 3 to 30 mg/mmol. Because the number of subjects with clinical microalbuminuria was small in this young age group, the 90th percentile of ACR or urinary albumin Ն 30 mg/L was used as a measure of increased albumin excretion, in accordance with previous studies. 3, 5 Cholesterol and triglycerides were measured by enzymatic procedures on the Abbott VP Analyzer (Abbott Laboratories, North Chicago, IL). High-density lipoprotein cholesterol levels were measured by a heparin-calcium precipitation procedure. 18 Cutoff points of 200 mg/dL or greater for triglycerides and below 35 mg/dL for HDL cholesterol were chosen to identify subjects with adverse levels of these variables. Glucose and uric acid were measured as part of a multiple chemistry profile in a multichannel Olympus Au-5000 analyzer (Olympus Corp, Lake Success, NY) by glucose oxidase and uricase methods, respectively. Immunoreactive insulin was determined by a commercial radioimmunoassay kit (Phadebas, Pharmacia Diagnostics, Piscataway, NJ). Insulin resistance index was calculated according to the homeostasis model assessment equation : 19 fasting insulin (U/mL) ϫ fasting glucose (mmol/L)/22.5. Although the euglycemic-hyperinsulinemic clamp method represents the standard for assessing insulin sensitivity, this model is considered useful to assess insulin resistance in epidemiologic studies. 20 A cutoff point of greater than 125 mg/dL for glucose was used to identify subjects with hyperglycemia. Subjects with insulin values greater than age-, race-, and gender-specific 90th percentile were classified as having hyperinsulinemia.
Statistical Analyses All analyses were performed using SAS software. Percentile (90th) used as cutoff point was age, race, and gender specific. Difference in the mean levels of the study variables by race and gender or the status of microalbuminuria within race were tested by analysis of covariance after controlling for age or age and gender. Differences in the prevalence of disorders by the status of microalbuminuria within race was determined by Pearson's 2 test or Fisher's exact test.
RESULTS
Levels of urinary albumin, creatinine, and ACR are given in Table 1 by race and gender. Significant race difference (African-Americans Ͼ Caucasians) in urinary albumin levels was noted only among women; gender difference (women Ͼ men) only among African-Americans. Urinary creatinine levels were significantly higher among African-Americans versus Caucasians, and men versus women. Urinary ACR showed significant gender differences (women Ͼ men), reflecting the lower creatinine excretion found in women compared with men. Table 2 compares the measures of general adiposity (BMI) and visceral fat deposition (waist circumference), BP, lipoprotein variables, measures of glucose homeostasis (glucose, insulin, and insulin resistance index), and uric acid in young adults with and without elevated ACR (Ն 90th percentile) by race, after controlling for age and gender. Unlike Caucasians, African-Americans with elevated ACR displayed significantly higher levels of both SBP and DBP. This trend remained when hypertensive subjects were excluded (data not shown). Unexpectedly, HDL cholesterol levels were higher in African-Americans with elevated ACR. None of the other risk variables related to insulin resistance syndrome listed in Table 2 showed significant difference between those with and without elevated ACR in both races. When this analysis was repeated by using the urinary albumin excretion of Ն 30 mg/L as the criterion for microalbuminuria, the above trends persisted ( Table 3 ). The prevalence of disorders related to insulin resistance syndrome (hypertension, hyperglycemia, hyperinsulinemia, and dyslipidemia) in young adults with and without elevated ACR are given by race in Table  4 . Of the disorders listed, hypertension was the only disorder associated significantly with elevated ACR, Abbreviations as in Tables 2 and 3 .
Values are in percent.
* Or treated for hypertension. † Age and gender specific.
ACR Ն 90th percentile v Ͻ 90th percentile in African-Americans. ‡ P Ͻ .05.
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again only in African-Americans. When urinary albumin excretion of Ն 30 mg/L was used as the criterion for microalbuminuria, the outcome was the same (data not shown).
DISCUSSION
The present community-based study shows that in the population of young adults there is a lack of relationship between microalbuminuria and the components of insulin resistant syndrome other than hypertension. An increase in HDL cholesterol level was noted in young African-Americans with microalbuminuria, in contrast to the expected decrease generally associated with the insulin resistant syndrome. Furthermore, as previously reported in this study cohort, 5 the observed association between microalbuminuria and elevated BP levels was apparent only among young African-Americans. It is of note that these data were derived from apparently healthy young adults in whom clinically significant renal dysfunction and the attendant proteinuria associated with type 2 diabetes and hypertension are generally uncommon.
It has been proposed that microalbuminuria is one facet of the insulin resistance syndrome even in healthy subjects. 3, 6 In general, the study subjects were mostly middle-aged and elderly in whom insulin resistance may occur as a consequence of aging process. 21 Moreover, in studies linking microalbuminuria and insulin resistance the subjects were either highly susceptible for type 2 diabetes 3 or disproportionately having impaired glucose tolerance and hypertension. 6 It should be noted that earlier studies in healthy subjects found no association between microalbuminuria and insulin resistance. 4, [12] [13] [14] Likewise, the present study found no increases in fasting insulin or insulin resistance index derived from a homeostasis model, both considered measures of insulin resistance, in young adults with elevated urinary albumin excretion. In addition, serum uric acid, an indicator of insulin resistance, 22 showed no association with urinary albumin excretion in this study.
Increases in intraglomerular capillary pressure, permeability of the glomerular capillary wall due to loss of charge and size selectivity, or both, are thought to cause leakage of albumin. 23, 24 Although vasodilatory action of hyperinsulinemia has been implicated in this process, 25 experimental evidence in this regard is lacking. 26 It is likely that the association of hyperinsulinemia/insulin resistance with microalbuminuria may be the consequence of concomitant presence of hypertension or type 2 diabetes. However, studies have shown that insulin resistance is unrelated to microalbuminuria in patients with type 2 diabetes 27 or hypertension. 28 The present finding that increased urinary albumin excretion is associated with hypertension confirms the well-known relationship. However, this relationship was seen only among young African-Americans, even after excluding known hypertensives. The BP levels in this study cohort were, as expected, significantly higher in African-Americans versus Caucasians (data not shown). That this African-American-Caucasian difference in BP was already apparent among children examined in the Bogalusa Heart Study 15 suggests a relatively higher long-term burden of pressor load in this group. It has been reported that the prevalence of microalbuminuria in hypertension was 2.3-fold higher in African-Americans versus Caucasians. 29 Several pathophysiologic factors have been identified as mediators of African-American excess in hypertension, 30 -33 some of which in turn may facilitate increased albumin excretion. For example, hypertension in African-Americans is commonly associated with higher salt sensitivity, 31 which is linked to increased albumin excretion and glomerular capillary pressure. 34 Regardless of the underlying mechanisms, microalbuminuria in young African-Americans may reflect early evidence of renal dysfunction induced by elevated levels of BP since childhood.
In the present study, the use of either 90th percentile of ACR or urinary albumin Ն 30 mg/L as a previously used indicator of microalbuminuria 3, 5 showed no increases in the prevalence of disorders related to insulin resistance syndrome other than hypertension in African-Americans. It is likely that the association between microalbuminuria and insulin resistance syndrome in young free-living individuals may be apparent only at a relatively higher threshold level of urinary albumin excretion. However, no such relationship was found even using higher threshold. 13 In conclusion, microalbuminuria is not an intrinsic component of insulin resistance syndrome in the population of young adults. That the urinary albumin excretion relates to BP levels in young African-Americans has implication for early prevention.
